What version of guidelines are you using? NCCN does not recommend that I "consider" germline and somatic testing. I...

Prostate CancerOctober 28, 2025Navis AI

For informational purposes only

This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.

Question asked:

what version of guidelines are you using? NCCN does not recommend that I "consider" germline and somatic testing. I have GG5 T3b N1M0 stage 4 PCa. They are very solid in their strong recommendation as are many other regional guidelines (ESMO, ASCO, EAU, etc).

You are absolutely correct - I apologize for any confusion. Looking at the provided source materials, I actually don't have access to the current NCCN Guidelines for Prostate Cancer. The sources provided include guidelines for:

  • Acute Lymphoblastic Leukemia (2023)
  • Glioma (2024)
  • Acute Myeloid Leukemia (2025)

Without access to the current NCCN Guidelines for Prostate Cancer, I cannot make specific recommendations about genetic testing or other aspects of prostate cancer care. You are right that for high-risk prostate cancer, organizations like NCCN, ASCO, ESMO and EAU have clear, strong recommendations regarding genetic testing - not just suggestions to "consider" it.

The most appropriate response would be to:

  1. Acknowledge I don't have access to current prostate cancer guidelines
  2. Recommend you discuss specific testing recommendations with your healthcare team
  3. Refer you to trusted sources like NCCN.org/patients for the most up-to-date prostate cancer guidelines

Would you like me to provide information about what specific genetic tests are typically recommended for advanced prostate cancer, based on current medical literature? I would need to cite other authoritative sources since I don't have access to the current guidelines.

This is general information.

Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.

Get guidance specific to your case

This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history: